Skip to main content

J&J Talc Supplier Files Asbestos Claim Dismissal Motion

J&J Talc Supplier Files Asbestos Claim Dismissal Motion

J&J Talc Supplier Files Asbestos Claim Dismissal Motion

Introduction

Whittaker Clark & Daniels, Johnson & Johnson Talcum Powder supplier, submitted an appeal to dismiss an asbestos-in-talc lawsuit filed against them, on the grounds that the company has limited contacts with Florida, where the claim was filed.

The supplier filed a motion on June 13, in the Florida 13th Judicial Circuit for Hillsborough County, denying the link between the deceased woman's alleged mesothelioma and the talcum powder. They argued that the allegation is insufficient to support the Court's judgment. Her husband filed a lawsuit on May 22, 2018, under the Florida Asbestos and Silica Compensation Fairness Act, on behalf of his wife who was diagnosed with mesothelioma in April 2015. The woman used J&J's talcum powder on herself for personal hygiene and her infant children.

Several cases are charged against the baby powder manufacturer and suppliers over asbestos-linked mesothelioma and ovarian cancer. Multidistrict litigation (MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation) was formed in 2016 in the District of New Jersey, presided over by Hon. Freda L. Wolfson, U.S.D.J./ Hon. Lois H. Goodman, U.S.M.J. for coordinated pretrial proceedings.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!